Clinical trial · Interventional
Eradication of Malignant Carcinoma in the Breast Tissue
The Eradication of Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor
NCT02286778CI-TRIAL-00028923completedPhase 2 / Phase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acetogenins | Dietary Supplement | — | UNRESOLVED |
| Placebo | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Acetogenins
- description
- Dietary Supplement: Acetogenins BID for 12 months
- interventionNames
- Dietary Supplement: Acetogenins
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- Dietary Supplement: No Acetogenins BID for 12 months
- interventionNames
- Dietary Supplement: Placebo
- type
- NO_INTERVENTION
- label
- Control
- description
- Control subjects will not receive the Acetogenins or the placebo. They will be evaluated every other month to monitor disease progress.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 35 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of breast cancer * Referred to the study by their treating physician Exclusion Criteria: * Any type of treatment for breast cancer before starting the study
References
Publications (0)
Data not yet available
No reference posted for this study.